{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:28:26Z","timestamp":1791044906663,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Chronic kidney disease (CKD) and non-alcoholic steatohepatitis (NASH) are major health issues associated with the metabolic syndrome. Although NASH is a known risk factor of CKD, the mechanisms linking these two diseases remain poorly understood. We aimed to investigate alterations in the kidney complicated with dyslipidemia in an established NASH mouse model. Male C57BL6\/J mice were fed with control diet or high-fat diet (HFD), containing 40% fat, 22% fructose, and 2% cholesterol for 16 weeks. Metabolic characteristics, histological changes in the kidney, endoplasmic reticulum (ER) stress, apoptosis, and fibrosis were evaluated by histological analysis, immunoblotting, and quantitative reverse transcription-polymerase chain reaction. Levels of serum aspartate aminotransferase, alanine aminotransferase, alkali-phosphatase, total cholesterol, and urinary albumin were significantly higher in mice fed with HFD. Remarkable steatosis, glomerular hypertrophy, and interstitial fibrosis were also shown in in the kidney by leveraging HFD. Furthermore, HFD increased the mRNA expression levels of <jats:italic>Casp3<\/jats:italic>, <jats:italic>Tgfb1<\/jats:italic>, and <jats:italic>Nfe2l2<\/jats:italic> and the protein level of BiP. We observed the early changes of CKD and speculate that the underlying mechanisms that link CKD and NASH are the induction of ER stress and apoptosis. Further, we observed the activation of <jats:italic>Nfe2l2<\/jats:italic> in the steatosis-induced CKD mouse model. This NASH model holds implications in investigating the mechanisms linking dyslipidemia and CKD.<\/jats:p>","DOI":"10.1371\/journal.pone.0265461","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:38:30Z","timestamp":1647452310000},"page":"e0265461","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model"],"prefix":"10.1371","volume":"17","author":[{"given":"Shintaro","family":"Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2959-6015","authenticated-orcid":true,"given":"Tomoaki","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Mae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Iyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-9258","authenticated-orcid":true,"given":"Tsutomu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Isomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"pone.0265461.ref001","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/jcm8111795","article-title":"Chronic Kidney Disease: The silent epidemy","volume":"8","author":"A Bellasi","year":"2019","journal-title":"J Clin Med."},{"key":"pone.0265461.ref002","first-page":"1","article-title":"Annual Dialysis Data Report 2016, JSDT Renal Data Registry.","volume":"4","author":"I Masakane","year":"2018","journal-title":"Ren Replace Ther"},{"key":"pone.0265461.ref003","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","article-title":"The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics","volume":"35","author":"DC Wheeler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0265461.ref004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10157-012-0709-0","article-title":"New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy","volume":"17","author":"M Namba","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"pone.0265461.ref005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm8010045","article-title":"Combination therapy with an SGLT2 inhibitor as initial treatment for type 2 diabetes: A systematic review and meta-analysis","volume":"8","author":"TY Milder","year":"2019","journal-title":"J Clin Med"},{"key":"pone.0265461.ref006","doi-asserted-by":"crossref","first-page":"19351","DOI":"10.1038\/s41598-019-55524-w","article-title":"Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis","volume":"9","author":"M Castellana","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0265461.ref007","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2215\/CJN.09870912","article-title":"Metabolic syndrome, ESRD, and death in CKD","volume":"8","author":"SD Navaneethan","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0265461.ref008","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"HR Jang","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0265461.ref009","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"CD Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"pone.0265461.ref010","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis","volume":"11","author":"G Musso","year":"2014","journal-title":"PLOS Med"},{"key":"pone.0265461.ref011","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2337\/diacare.27.8.2057","article-title":"Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis","volume":"27","author":"J Medina","year":"2004","journal-title":"Diabetes Care"},{"key":"pone.0265461.ref012","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/ijms21010190","article-title":"Ipragliflozin ameliorates endoplasmic reticulum stress and apoptosis through preventing ectopic lipid deposition in renal tubules","volume":"21","author":"K Hosokawa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0265461.ref013","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","article-title":"Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source","volume":"25","author":"ML Boland","year":"2019","journal-title":"World J Gastroenterol"},{"key":"pone.0265461.ref014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.33160\/yam.2020.08.003","article-title":"Oligopeptide transporter-1 is associated with fluorescence intensity of 5-aminolevulinic acid-based photodynamic diagnosis in pancreatic cancer cells","volume":"63","author":"H Kinoshita","year":"2020","journal-title":"Yonago Acta Med"},{"key":"pone.0265461.ref015","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.3390\/ijms15045762","article-title":"Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"15","author":"SM Kessler","year":"2014","journal-title":"Int J Mol Sci"},{"key":"pone.0265461.ref016","doi-asserted-by":"crossref","first-page":"20157","DOI":"10.1038\/srep20157","article-title":"Involvement of resistin-like molecule \u03b2 in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice","volume":"6","author":"H Okubo","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0265461.ref017","doi-asserted-by":"crossref","first-page":"19601","DOI":"10.1038\/s41598-019-56039-0","article-title":"Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis","volume":"9","author":"M Asakawa","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0265461.ref018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.33160\/yam.2019.03.006","article-title":"Gene expression analysis of the activating factor 3\/nuclear protein 1 axis in a non-alcoholic steatohepatitis mouse model","volume":"62","author":"R Nagahara","year":"2019","journal-title":"Yonago Acta Med"},{"key":"pone.0265461.ref019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.33160\/yam.2019.03.005","article-title":"Protective effects of ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, on a non-alcoholic steatohepatitis mouse model","volume":"62","author":"M Yamane","year":"2019","journal-title":"Yonago Acta Med"},{"key":"pone.0265461.ref020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-5793(97)00732-1","article-title":"Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob\/ob) mice","volume":"411","author":"YL Liu","year":"1997","journal-title":"FEBS Lett"},{"key":"pone.0265461.ref021","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/diab.46.5.887","article-title":"A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL\/6 (Akita) mutant mice","volume":"46","author":"M Yoshioka","year":"1997","journal-title":"Diabetes"},{"key":"pone.0265461.ref022","doi-asserted-by":"crossref","first-page":"F1008","DOI":"10.1152\/ajprenal.00597.2013","article-title":"Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus","volume":"306","author":"SK Mallipattu","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"key":"pone.0265461.ref023","doi-asserted-by":"crossref","first-page":"32317","DOI":"10.1074\/jbc.M500801200","article-title":"Diet-induced obesity in C57BL\/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway","volume":"280","author":"T Jiang","year":"2005","journal-title":"J Biol Chem"},{"key":"pone.0265461.ref024","doi-asserted-by":"crossref","first-page":"F118","DOI":"10.1152\/ajprenal.00110.2008","article-title":"Structural and functional changes in the kidneys of high-fat diet-induced obese mice","volume":"296","author":"N Deji","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"key":"pone.0265461.ref025","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1096\/fasebj.4.9.2189777","article-title":"Metabolic effects of dietary fructose","volume":"4","author":"J. Hallfrisch","year":"1990","journal-title":"FASEB J"},{"key":"pone.0265461.ref026","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"JR Clapper","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"pone.0265461.ref027","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","article-title":"Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indicies of nonalcoholic steatohepatitis in mice","volume":"302","author":"JL Trevaskis","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"pone.0265461.ref028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13098-018-0307-8","article-title":"Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats","volume":"10","author":"VS Jensen","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"pone.0265461.ref029","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1681\/ASN.2019101015","article-title":"Fructose Production and Metabolism in the Kidney","volume":"31","author":"T Nakagawa","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"pone.0265461.ref030","doi-asserted-by":"crossref","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","article-title":"Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent","volume":"295","author":"LH Tetri","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"pone.0265461.ref031","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10495-009-0341-y","article-title":"Cellular responses to endoplasmic reticulum stress and apoptosis","volume":"14","author":"VI Rasheva","year":"2009","journal-title":"Apoptosis"},{"key":"pone.0265461.ref032","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1083\/jcb.150.4.887","article-title":"Cross-talk between two cysteine protease families: Activation of caspase-12 by calpain in apoptosis","volume":"150","author":"T Nakagawa","year":"2000","journal-title":"J Cell Biol"},{"key":"pone.0265461.ref033","doi-asserted-by":"crossref","first-page":"34287","DOI":"10.1074\/jbc.M204973200","article-title":"An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12","volume":"277","author":"N Morishima","year":"2002","journal-title":"J Biol Chem"},{"key":"pone.0265461.ref034","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2183\/pjab.85.314","article-title":"Transforming growth factor-\u03b2 signaling in epithelial-mesenchymal transition and progression of cancer","volume":"85","author":"K. Miyazono","year":"2009","journal-title":"Proc Jpn Acad B"},{"key":"pone.0265461.ref035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/BOR.0b013e3283588dbb","article-title":"The role of endoplasmic reticulum stress and the unfolded protein response in fibrosis","volume":"24","author":"S Lenna","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"pone.0265461.ref036","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajpath.2013.05.008","article-title":"Pathological in situ reprogramming of somatic cells by the unfolded protein response","volume":"183","author":"H Johno","year":"2013","journal-title":"Am J Pathol"},{"key":"pone.0265461.ref037","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/0886022X.2019.1641413","article-title":"High glucose and TGF-\u03b21 reduce expression of endoplasmic reticulum-resident selenoprotein S and selenoprotein N in human mesangial cells","volume":"41","author":"F Huang","year":"2019","journal-title":"Ren Fail"},{"key":"pone.0265461.ref038","first-page":"G697","article-title":"Obesity, diabetes mellitus, and liver fibrosis","volume":"300","author":"DJ Chiang","year":"2011","journal-title":"Am J Physiol Liver Physiol"},{"key":"pone.0265461.ref039","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cld.2009.07.003","article-title":"Apoptosis and cytokines in non-alcoholic steatohepatitis","volume":"13","author":"WK Syn","year":"2009","journal-title":"Clin Liver Dis"},{"key":"pone.0265461.ref040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41401-019-0297-6","article-title":"A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1\/Nrf2 signaling","volume":"41","author":"L Du","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"pone.0265461.ref041","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2337\/db11-0807","article-title":"Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy","volume":"60","author":"H Zheng","year":"2011","journal-title":"Diabetes"},{"key":"pone.0265461.ref042","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"HK Bryan","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"pone.0265461.ref043","first-page":"821936","article-title":"Prevention of diabetic nephropathy by sulforaphane: Possible role of Nrf2 upregulation and activation","volume":"2012","author":"W Cui","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"pone.0265461.ref044","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/1351000214Y.0000000087","article-title":"Combating oxidative stress in diabetic complications with Nrf2 activators: How much is too much","volume":"19","author":"SM Tan","year":"2014","journal-title":"Redox Rep"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0329654","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:39:16Z","timestamp":1647452356000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265461"}},"subtitle":[],"editor":[{"given":"David","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0265461","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}